Dr. Nambi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6655 Travis St
Houston, TX 77030Phone+1 713-798-5800Fax+1 713-798-7885- Is this information wrong?
Education & Training
- Baylor College of MedicineFellowship, Cardiovascular Disease, 2003 - 2006
- Cleveland Clinic FoundationResidency, Internal Medicine, 1999 - 2002
- University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 1998 - 1999
- Madras Medical CollegeClass of 1998
Certifications & Licensure
- TX State Medical License 2005 - 2025
- OH State Medical License 2000 - 2003
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Biomarker Guided Therapies in Stage A/B Heart Failure Start of enrollment: 2014 Oct 01
Publications & Presentations
PubMed
- Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1.Seyedmohammad Saadatagah, Mohammadreza Naderian, Mesbah Uddin, Ozan Dikilitas, Abhishek Niroula, Art Schuermans, Elizabeth Selvin, Ron C Hoogeveen, Kunihiro Matsushita...> ;JAMA Cardiology. 2024 Apr 10
- HDL Therapeutics - Time for a Curtain Call or Time to Reconceptualize?Christie M Ballantyne, Vijay Nambi> ;The New England Journal of Medicine. 2024 Apr 6
- Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States.Abdul Mannan Khan Minhas, Roy O Mathew, Michael D Shapiro, Laurence S Sperling, Vijay Nambi, Salim S Virani, Sankar D Navaneethan, Dmitry Abramov> ;Journal of the American College of Cardiology. 2024 Apr 1
- Join now to see all
Journal Articles
- Associations Between Carotid Artery Plaque Burden, Plaque Characteristics, and Cardiovascular EventsSalim S Virani, Vijay Nambi, Christie M Ballantyne, JAMA Cardiology
- Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass IndexRohan Khera, Vijay Nambi, Stephen L Seliger, Monika M Safford, Robert J Mentz, Donald M Lloyd-Jones, Ian J Neeland, JAMA Network Open
- Original Investigation Remnant-like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular DiseaseChristie M Ballantyne, Anum Saeed, Vijay Nambi, Salim S Virani, Cameron S Guild, ScienceDirect
Lectures
- Safety of Evolocumab in People Living with HIV Infection an Important First StepAmerican Heart Association, Scientific Sessions 2011, Orlando, Florida, USA
- Safety of Evolocumab in People Living with HIV Infection an Important First StepScientific Sessions 2011, Orlando, Florida, USA
- So You Know Your Lipids! Let's Ask Some Questions and Discuss Some Cases2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Authored Content
- Safety of Evolocumab in People Living with HIV Infection an Important First StepMay 2020
Press Mentions
- Uptick in Natriuretic Peptides with Long-Term Serial Testing Predicts New Heart FailureFebruary 14th, 2023
- Uptake Uncertain for Potent New LDL-Lowerer InclisiranJanuary 26th, 2022
- As COVID-19 Drags on, the Cardiology Fallout May Haunt for YearsDecember 16th, 2021
- Join now to see all
Grant Support
- Improving Cardiovascular Risk Assessment Using Ultrasound ImagingNational Heart, Lung, And Blood Institute2009–2011
Hospital Affiliations
- Ben Taub General HospitalHouston, Texas
- Houston Methodist HospitalHouston, Texas
- St. Luke's Health - Baylor St. Luke's Medical CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: